Impulse oscillometry in COPD: Identification of measurements related to airway obstruction, airway conductance and lung volumes  by Kolsum, Umme et al.
Respiratory Medicine (2009) 103, 136e143ava i lab le a t www.sc iencedi rec t .com
journa l homepage : www.e lsev ie r . com/ loca te / rmedImpulse oscillometry in COPD: Identification
of measurements related to airway obstruction,
airway conductance and lung volumesUmme Kolsum a,*, Zoe¨ Borrill a, Kay Roy a, Cerys Starkey a,
Jørgen Vestbo a,b, Catherine Houghton c, Dave Singh aa North West Lung Research Centre, University of Manchester, South Manchester University Hospitals Trust,
Southmoor Road, Wythenshawe, Manchester M23 9LT, UK
b Department of Cardiology and Respiratory Medicine, Faculty of Health Sciences,
Hvidovre University Hospital, Hvidovre, Denmark
c Fairfield General Hospital, Pennine Acute Hospitals Trust, Bury BL9 7TD, UK
Received 30 January 2008; accepted 14 July 2008
Available online 28 August 2008KEYWORDS
COPD;
Impulse oscillometry
system;
Spirometry;
Body Plethysmography* Corresponding author. Tel.: þ44 (0
E-mail address: ukolsum@meu.org
0954-6111/$ - see front matter ª 200
doi:10.1016/j.rmed.2008.07.014Summary
Background: Impulse oscillometry system (IOS) assesses pulmonary resistance and reactance.
We set out to investigate which IOS measurements are related to airflow obstruction, airway
conductance and lung volumes in chronic obstructive pulmonary disease (COPD).
Methods: Ninety-four COPD patients were recruited and 58 agreed to follow up after 1 year.
IOS measurements (R5, R20, X5 & Fres), body plethysmography (sGaw, FRC, TLC, RV & IC)
and spirometry (FEV1) were performed. Pearson or Spearman correlation determined the
relationships between IOS and other measurements.
Results: R5, X5 and Fres were all significantly associated (p< 0.05) with FEV1, sGaw, TLC, RV
and IC. However, R20 was not related to any of these measurements except for RV. The stron-
gest associations were observed between FEV1 and the reactance measurements X5 (rZ 0.48)
and Fres (rZ0.44), and sGaw with X5 (rZ 0.47) and Fres (rZ 0.51). The r values for the
associations with TLC and IC were all <0.25.
There was no statistically significant change in the FEV1, R5, X5 or Fres after 1 year, but R20
significantly increased over the year. The changes in R5 and R20 did not significantly correlate
with the changes in FEV1. In contrast, X5 changes were significantly related to FEV1 changes
over 1 year (rZ 0.27, pZ 0.05), while for Fres changes there was a trend to statistical
significance (pZ 0.08).
Conclusions: IOS reactance measurements are more closely related than resistance measure-
ments to other pulmonary function measurements in COPD patients. The IOS reactance)161 9464065; fax: þ44 (0)161 9461459.
.uk (U. Kolsum).
8 Elsevier Ltd. All rights reserved.
Impulse oscillometry in COPD 137measurements appear to be indicative of changes in pulmonary compliance caused by airflow
obstruction.
ª 2008 Elsevier Ltd. All rights reserved.Table 1 Patient demographics at baseline.
Gender, male/female 63/31
Age (years)a 63.81 (7.76)
Current/Ex Smokers 35/59
Smoking history (pack years)b 42 (35e53.5)
ICS use/no use 52/42
LABA use/no use 43/51
LANC use/no use 17/77
Methylxanthines use/no use 7/87
There were no patients on oral corticosteroids.
Abbreviations: ICS, inhaled corticosteroids; LABA, long acting
bronchodilator; and LANC, long acting anticholinergic.
a Data represented as mean (SD).
b Data represented as median (IQR).Introduction
Chronic obstructive pulmonary disease (COPD) is defined by
poorly reversible airflow limitation caused by the inhalation
of noxious particles such as cigarette smoke.1 COPD patients
display heterogeneous pathophysiological abnormalities
including small airway disease, hyperinflation and mucus
hypersecretion, all of which may cause airflow obstruction.2
Spirometry is the ‘gold standard’ by which airflow
obstruction is assessed in COPD patients. Forced expiration
is used as part of spirometry in the diagnosis and staging of
COPD. This procedure can be difficult for patients to
perform as it is effort dependent and can alter broncho-
motor tone. Body plethysmography is an alternative
pulmonary function technique, allowing assessment of
airways resistance and conductance. However, it can be
technically demanding for patients to perform as it requires
complex ‘panting’ manoeuvres. Thus, there is a need for
easy to perform but physiologically accurate methods to
assess pulmonary mechanics in COPD patients.
The forced oscillation technique (FOT) was developed in
1956 to measure the impedance of the respiratory system
through application of small pressure oscillations at the
mouth during normal breathing.3 FOT systems use
pseudorandom noise signals to enable the simultaneous
measurement of respiratory resistance (Rrs) and reactance
(Xrs). It has been reported that FOT measurements are
associated with traditional lung function measurements in
patients with obstructive lung disease.4,5 In COPD patients
specifically, it has been shown that FOT resistance measure-
ments canbeused to sensitively diagnosemildCOPD, but that
reactance measurements are better for grading severity of
disease.6 The authors of this paper point out that FOT
provides unique data on respiratory mechanics that is
complimentary to spirometry. However, they also point out
that there is little consensus in the literature as to the best
FOT parameters for evaluating respiratory mechanics.
The impulse oscillometry system (IOS)7 is a typeof FOTbut
with 2 important differences; rectangular waveform
impulses are applied instead of pseudorandom noise signals,
and the IOS has a different set of data outputs. IOS has been
used in clinical trials to examine drug effects8,9; COPD and
asthma studies have shown IOS measurements to be more
sensitive than FEV1 for measuring the pulmonary effects of
bronchodilator drugs.10e12 Additionally, IOS measurements
can be used to sensitively diagnose obstructive lung
disease.13,14 Hellincx et al.15 reported that IOS gives similar
but not identical respiratory resistance and reactance
measurements compared to FOT, underscoring that these
techniques may give different results.
While there is information for FOT using pseudorandom
noise generation,4,6 it is not known which IOS parameters are
the most informative when assessing the severity of COPD.
Importantly,weneed to understandwhich IOSmeasurements
are related to the degree of airflow obstruction as measuredby forced expiratory volume in 1 s (FEV1), and which are
related to the degree of hyperinflation measured by lung
volumes. This paper describes the relationship of IOS
measurements to other pulmonary functionmeasurements in
a large cohort of COPD patients (nZ 94). We followed up
these patients for 1 year, and then compared the changes in
IOS and FEV1 measurements over 1 year.
Methods
Subjects
Ninety-four patients with COPD were recruited from primary
carebymedia advertising intoour cohort formeasurementof
pulmonary function (see Table 1 for demography). All
patients were invited to attend 1 year later; 58 patients
agreed to participate, with the remainder unable to do so or
havingwithdrawn consent. COPDwas diagnosed according to
current GOLD guidelines,1 based on a smoking history of at
least 10 pack years together with typical symptoms (one or
more of productive cough, breathlessness and wheeze) and
evidence of airflow obstruction. Patients with a clinical
history of asthma, an exacerbation or any change in their
COPD therapywithin 4weeks of the study, or a history of lung
cancer were excluded. Written informed consent was
obtained and the local ethics committee approved the study.
Study design
Each patient performed pulmonary function tests in the
following order; impulse oscillometry system (IOS), body
plethysmography (including measurement of lung volumes)
and spirometry.
Pulmonary function measurements
IOS (Masterscreen IOS, Erich Jaeger, Hoechberg, Germany)
measurements were performed as previously described,12
138 U. Kolsum et al.and the actual values of respiratory resistance at 5 and 20 Hz
(R5 and R20, respectively), reactance at 5 Hz (X5) and
resonant frequency (Fres) were recorded. sGaw, functional
residual capacity (FRC), vital capacity (VC) and inspiratory
capacity (IC) were measured in a constant volume plethys-
mograph (Sensormedics Vmax 6200). Total lung capacity
(TLC) and residual volume (RV) were then calculated from
these parameters. IOS and body plethysmograph measure-
ments were performed in triplicate and the mean used for
further analysis. FEV1 was measured using the spirometry
system on the Masterscreen. Readings were again performed
in triplicate, with the highest FEV1 recorded.
Statistical analysis
The KolmogoroveSmirnov test was applied to determine
the normality of data. Non-parametric data was natural log
transformed, X5 and R5 data remained non-parametric
despite natural log transformation. Data is represented as
means and 95% confidence intervals (95% CI) unless other-
wise specified. Pearson correlation or Spearman correlation
was applied to determine the relationships between the
baseline IOS and pulmonary function measurements and the
relationships between the change in FEV1 and change in IOS
over 1 year. Paired t test or the Wilcoxon matched pair test
was performed to determine the differences between the 2
visits over a year. P< 0.05 was considered statistically
significant. Statistical analyses were performed using SPSS
(Chicago; USA).
Results
Baseline patient demographics and pulmonary function
measurements are shown in Tables 1 and 2, respectively. The
study population was composed of patients with moderate
disease severity with a mean FEV1% predicted of 57.9%.
Relationships between IOS and other pulmonary
function measurements
R5, X5 and Fres were all significantly associated with FEV1,
with the reactance measurements X5 (rZ 0.48) and FresTable 2 Pulmonary function at the baseline visit.
Mean (SD)
FEV1 (% predicted) 57.9 (13.1)
sGAWa (kPa s) 0.482 (0.44e0.53)
FRC (% predicted) 133.4 (28.3)
IC (L) 2.3 (0.6)
TLC (% predicted) 107.3 (16.3)
RV (% predicted) 148.0 (36.5)
R5b (kPa L s) 0.605 (0.515e0.817)
R20a(kPa L s) 0.394 (0.369e0.420)
X5b (kPa L s) 0.283 (0.449, 0.163)
Fres (Hz) 25.12 (7.1)
Lung function measurements were standardised for age and
gender.
a Data represented as geometric mean (95% CI).
b Data represented as median (IQR).(rZ0.44) showing the strongest degree of association
(Fig. 1). R20 did not correlate with FEV1.
TLC (Fig. 2), IC (Fig. 3) and sGaw (Fig. 4) were signifi-
cantly associated with R5, X5 and Fres, but not R20. The r
values for the associations with TLC and IC were all <0.25.
In contrast there was a stronger degree of association for
sGaw, particularly for Fres (rZ 0.51). RV was significantly
correlated with R5 (rZ 0.35, pZ 0.0007), R20 (rZ 0.20,
pZ 0.05), X5 (rZ0.36, pZ 0.0002) and Fres (rZ 0.31,
pZ 0.003). None of the IOS measurements were signifi-
cantly correlated with FRC (p> 0.05).
Comparison of FEV1 and IOS measurements
over 1 year
To compare changes in FEV1 and IOS measurements over
1 year in 58 patients at follow up, we considered changes in
group statistics and changes within each individual. For the
overall group mean or median values, there was no statis-
tically significant change in the FEV1, R5, X5 or Fres after
1 year (Table 3). However, R20 significantly increased over
the years.
The relationships between changes in FEV1 and IOS
measurements within each individual over 1 year are shown
in Fig. 5. The changes in R5 and R20 did not significantly
correlate with the changes in FEV1. In contrast, X5 changes
were significantly related to FEV1 changes over 1 year
(rZ0.27, pZ 0.05), while for Fres changes there was
a trend to statistical significance (pZ 0.08).
Discussion
In our initial assessment of 94 COPD patients, we observed
R5, X5 and Fres to be significantly associated with measures
of airwayobstruction (FEV1), airwayconductance (sGaw)and
hyperinflation (TLC, RV and IC). However, R20 was not
related to any of these measurements except for RV. The
strongest associations were observed between reactance
measurements and both FEV1 and sGaw. FEV1 is a well
recognized measurement of airflow obstruction, while sGaw
is a less commonly used but extremely sensitive measure-
ment of airflow obstruction.8,10e12 Thus, the key novel
finding of this study is that IOS reactance measurements are
more informative than resistance measurements about the
changes in pulmonary mechanics caused by airflow obstruc-
tion inCOPDpatients. Indeed, R20 appears to beunrelated to
the severity of airflow obstruction.
Further evidence of the close association of reactance
measurements to FEV1 was found when 58 patients were
followed up at 1 year; changes in X5 and FEV1 over 1 year
were significantly related, while there was a trend towards
an association between Fres and FEV1 changes. Our data at
the baseline visit and for the change over 1 year is similar to
the findings of Di Mango et al.6 using FOT methods; they
reported that reactance measurements were better than
resistance measurements for grading severity of airflow
obstruction in COPD. The novelty of the current study is
that1 we have evaluated the IOS system which provides
different data parameters to classic FOT systems and2 we
have considered whether IOS measurements relate to
hyperinflation or airway conductance in addition to the
standard measurement of FEV1.
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Figure 1 Relationship between IOS measurements and FEV1 % predicted at the baseline visit (a) R5 vs. FEV1 (b) R20 vs. FEV1
(c) X5 vs. FEV1 and (d) Fres vs. FEV1. NSZ not statistically significant (p> 0.05).
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tance measurements (rZ 0.48 for X5 and rZ0.44 for
Fres), and between sGaw and reactance measurements
(rZ 0.47 for X5 and rZ 0.51 for Fres) suggests a moderate
association between IOS airway reactance measurements
and airflow obstruction, whether assessed by FEV1 or sGaw.0
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vs. TLC and (d) Fres vs. TLC. NSZ not statistically significant (p>IOS is therefore not a replacement for FEV1, but as previously
pointed out for classic FOTmethods provides complimentary
information on respiratory mechanics.6 IOS reactance
measurements provide insights into changes in pulmonary
compliance associated with the severity of airflow obstruc-
tion. In contrast, IOS reactance measurements appear to be0
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140 U. Kolsum et al.less indicative of mechanical changes due to hyperinflation
as the r values for these associations were <0.25.
Respiratory reactance is thought to be a composite
measurement of both lung compliance and inertiance. Iner-
tiance measurements are usually clinically irrelevant, and
reactance changes in pulmonary disease are dominated by
respiratory compliance.16 Compliance is a measure of how a
c d
b
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Table 3 Comparison of FEV1 and IOS measurements between the baseline visit and year 1 visit.
Baseline Year 1 p Value
FEV1 (% predicted) 56.7 (13.1) 57.5 (13.3) 0.54
R5b (kPa L s) 0.640 (0.557e0.856) 0.698 (0.564e0.932) 0.57
R20a(kPa L s) 0.416 (0.383e0.451) 0.442 (0.413e0.474) 0.03
X5b (kPa L s) 0.308 (0.453,0.190) 0.307 (0.446, 0.187) 0.80
Fres (Hz) 26.5 (7.1) 26.7 (6.5) 0.86
Data represented as mean (SD) unless otherwise specified.
a Data represented as geometric mean (95% CI).
b Data represented as median (IQR).
Impulse oscillometry in COPD 141obstruction, even though lung tissue compliance can be
increased in emphysema patients due to parenchymal tissue
destruction.
Fres is the point at which compliance and inertial reac-
tancemagnitudes are equal and opposite, thus X is zero. This
occurs at a higher frequency with reduced respiratory
compliance. Both Fres and X5measurements were related to
the degree of airflow obstruction (measured by FEV1), and
the degree of hyperinflation (measured by lung volumes).
Lung tissue destruction in emphysema patients causing
hyperinflation should increase lung tissue compliance, but
we have shown that hyperinflation is associated with
decreased pulmonary compliance. Hyperinflation can cause
airflow obstruction, which decreases pulmonary compli-
ance. Our data therefore suggests that the associations
between IOS reactance measurements and lung volumes are
due to the airflow obstruction that occurs in patients with
hyperinflation.-0.8
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NSZ not statistically significant (p> 0.05).Previous oscillometry studies have demonstrated that
peripheral airway obstruction is characterised by a greater
increase in the resistance at low frequencies (R5) compared
to the higher frequencies (R20),7,17,18 often called frequency
dependence of resistance. Thus R5 is thought of as
a measurement of peripheral airway obstruction. It is well
documented that COPD patients demonstrate frequency
dependence of resistance.19 The current study showed that
R5, but not R20, was associated with FEV1 at the baseline
visit. This adds further weight to the evidence that low
frequency IOS resistance measurements can be used to
assess peripheral airway obstruction in COPD patients. In
contrast, R20 measurements appear to be unrelated to
airflow obstruction in COPD patients, and the value of these
measurements in COPD patients must be questionable. Our
findings also support several studies in asthma and COPD
patients where R20 was found to be less sensitive than R5 at
detecting bronchodilation.9e13-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
-30 -20 -10 10 20 30 40
Change in FEV1 (% predicted)
C
h
a
n
g
e
 
i
n
 
R
2
0
 
(
k
P
a
.
L
.
s
e
c
)
-20
-15
-10
-5
0
5
10
15
-30 -20 -10 10 20 30 40
Change in FEV1 (% predicted)
C
h
a
n
g
e
 
i
n
 
F
r
e
s
 
(
H
z
)
b
NS
r=-0.24, p=0.08
d
0
0
hin each individual over a 1 year interval (a) Change in R5 vs.
5 vs. change in FEV1 and (d) Change in Fres vs. change in FEV1.
142 U. Kolsum et al.At the 1 year follow up we found X5 was the only IOS
measurement that significantly correlated with FEV1
changes. These findings further underscore the potential
utility of X5 as an alternative measurement of pulmonary
mechanics in COPD patients that is physiologically rele-
vant and associated with changes in FEV1. Previous
studies have shown that X5 is sensitive to the therapeutic
effects of bronchodilators 10,12 and that analysis of the
differences between inspiratory and expiratory reactance
can be used to identify COPD patients with expiratory
flow limitation.20 We did not assess inspiratory and
expiratory reactance. This does not negate the value of
the current study, as IOS is often performed in clinical
practice without assessment of inspiratory and expiratory
values.
There are many practical issues that need to be
considered when deciding which pulmonary function
measurement will provide the best method of assessing
COPD. Whilst spirometry is the widely accepted method to
measure airflow obstruction, it can exhaust patients to
perform and is effort dependent. Similar problems also
exist for the body plethysmography. Alternatively IOS is an
easy procedure to perform that requires only tidal
breathing. However, there are other issues that should be
further addressed before IOS is considered an alternative to
FEV1 in clinical practice. Firstly, the 1 year follow up in the
current study could be argued to be relatively short, and
further assessment of changes in IOS parameters is war-
ranted over longer periods and in a larger sample size with
the inclusion of more severe patients. Secondly, the eval-
uation of IOS measurements in COPD patients during
exacerbations would be interesting. These studies would
allow IOS measurements to be compared to changes in FEV1
as well as other well recognized pulmonary function
parameters such as IC and RV that categorize the severity
of COPD.
Lastly, the actual values for IOS were used for analysis in
this study, as one of the limitations of IOS in a clinical
setting is the lack of definitive predictive equations,
especially for adults. Although, there has been little vari-
ation in resistance values in the few studies that have
reported reference values in healthy subjects, it should be
noted that these studies were limited by selection criteria
or sample size.17,18,21 Thus, the European Respiratory
Society Task Force Report22 has recently highlighted the
need for further large scale studies across a wider age
range to validate existing reference values.
In summary, we have shown X5 and Fres to be the IOS
measurements most closely associated with more tradi-
tional measurements of pulmonary function in COPD
patients. These reactance measurements are related to the
degree of airflow obstruction, and offer an alternative to
FEV1. The ease of use of IOS and the sensitivity of this
technique to measure the effects of therapeutic interven-
tions in COPD patients9 should provide a sound basis for the
increased use of this method in clinical practice.
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